VanEck Biotech ETF
BBH
BBH
112 hedge funds and large institutions have $158M invested in VanEck Biotech ETF in 2021 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 26 increasing their positions, 27 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0.59% less ownership
Funds ownership: 28.08% → 27.49% (-0.59%)
4% less repeat investments, than reductions
Existing positions increased: 26 | Existing positions reduced: 27
Holders
112
Holding in Top 10
–
Calls
$2.72M
Puts
$484K
Top Buyers
| 1 | +$1.94M | |
| 2 | +$1.67M | |
| 3 | +$1.49M | |
| 4 |
PP
Prudential plc
London, England,
United Kingdom
|
+$1.01M |
| 5 |
Millennium Management
New York
|
+$638K |
Top Sellers
| 1 | -$3.1M | |
| 2 | -$2.27M | |
| 3 | -$2.22M | |
| 4 |
BRC
BHF RG Capital
Scottsdale,
Arizona
|
-$2.13M |
| 5 |
Goldman Sachs
New York
|
-$571K |